Your email has been successfully added to our mailing list.

×
0 -0.0463917525773196 -0.0463917525773196 -0.0368041237113403 0.0257731958762886 0.017061855670103 -0.0206185567010309 -0.0604639175257733
Stock impact report

UPDATE 1-Forward Pharma loses appeal in Tecfidera patent dispute with Biogen [Reuters (UK)]

Forward Pharma A/S - American Depositary Shares (FWP) 
Last forward pharma a/s - american depositary shares earnings: 4/18 05:15 pm Check Earnings Report
US:NASDAQ Investor Relations: forward-pharma.com
Company Research Source: Reuters
Forward Pharma loses appeal in Tecfidera patent dispute with Biogen | Reuters 2 Min Read (Reuters) - A U.S. federal appeals court on Wednesday upheld a ruling that Biogen Inc’s patents on its blockbuster multiple sclerosis drug Tecfidera are valid, rejecting a challenge by Danish drugmaker Forward Pharma A/S. The U.S. Court of Appeals for the Federal Circuit said it agreed with a March 2017 ruling by the Patent Trial and Appeal Board that freed Biogen ( BIIB.O ) from future royalty payments to Forward. Forward said in a statement it was disappointed with the ruling and considering its options. Biogen did not immediately respond to a request for comment. The companies had been locked in a dispute over patents for dimethyl fumarate, the key active ingredient in Tecfidera, the leading oral MS treatment. Tecfidera had sales of about $4.2 billion in 2017. Biogen’s Tecfidera exclusivity in the United States is secured through 2028 under the ruling. In January 2017, Biogen took out an insu Show less Read more
Impact Snapshot
Event Time:
FWP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for FWP alerts
Opt-in for
FWP alerts

from News Quantified
Opt-in for
FWP alerts

from News Quantified